Share Name Share Symbol Market Type Share ISIN Share Description
Ixico Plc LSE:IXI London Ordinary Share GB00BFXR4C20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.25 -3.09% 70.50 69.00 72.00 74.00 70.50 72.75 104,133 15:43:47
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 5.4 -0.8 -2.0 - 33

IXICO plc Director/PDMR Shareholding

11/09/2019 7:01am

UK Regulatory (RNS & others)

Ixico (LSE:IXI)
Historical Stock Chart

3 Months : From Aug 2019 to Nov 2019

Click Here for more Ixico Charts.


RNS Number : 8752L


11 September 2019

11 September 2019


("IXICO" or the "Company")

PDMR share option exercise and TVR

IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, announces that on 10 September 2019, John Hall, SVP Corporate Development, exercised 87,647 share options in the Company resulting in the allotment of new ordinary shares. 50,000 of these shares are allotted at a price of 36.5p and 37,647 of these shares are allotted at a price of 49p.

John Hall is interested in 183,094 Ordinary Shares, representing 0.4 per cent of the enlarged issued share capital of the Company following the exercise of options.

Application has been made to the London Stock Exchange for the admission to trading on AIM of 87,647 new ordinary shares of 1p each ("New Shares") to satisfy the exercise of options. The New Shares are expected to be admitted to trading on AIM on 16 September 2019.

Total voting rights

Application has been made for admission to trading on AIM of 87,647 New Shares. Admission of the New Shares on AIM is expected to become effective at 8.00a.m. on 16 September 2019, following which there will be in total 46,902,294 ordinary shares in the capital of the Company in issue, each carrying equal voting rights.

This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, IXICO under the FCA's Disclosure and Transparency Rules.

 1     Details of the person discharging managerial responsibilities 
        / person closely associated 
 a)    Name                                     John Hall 
      ---------------------------------------  ---------------------------------- 
 2     Reason for the notification 
 a)    Position/status                          SVP Corporate Development 
      ---------------------------------------  ---------------------------------- 
 b)    Initial notification                     Initial notification 
      ---------------------------------------  ---------------------------------- 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
 a)    Name                                     IXICO plc 
      ---------------------------------------  ---------------------------------- 
 b)    LEI                                      2138005M1F59O6HWSA97 
      ---------------------------------------  ---------------------------------- 
 4     Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions 
        have been conducted 
 a)    Description of the                       Ordinary Shares in IXICO plc 
        financial instrument, 
        type of instrument 
       Identification code                      GB00BCLY7L40 
 b)    Nature of the transaction                Exercise of share options 
      ---------------------------------------  ---------------------------------- 
 c)    Price(s) and volume(s) 
                                                --------------  --------------- 
                                                 Price(s)        Volume(s) 
                                                --------------  --------------- 
                                                 49p             37,647 
                                                --------------  --------------- 
                                                 36.5p           50,000 
                                                --------------  --------------- 
 d)    Aggregated information 
  - Aggregated volume                      87,647 shares 
  - Price                                  41.9p 
 e)    Date of the transaction                  10/09/19 
      ---------------------------------------  ---------------------------------- 
 f)    Place of the transaction                 Outside of a trading venue 
      ---------------------------------------  ---------------------------------- 
 IXICO plc                                        +44 (0) 20 3763 7498 
 Giulio Cerroni, Chief Executive Officer 
  Grant Nash, Chief Financial Officer 
 Cenkos Securities PLC (Nominated adviser 
  and sole broker)                                +44 (0) 20 7397 8900 
 Giles Balleny / Max Gould (Corporate Finance) 
 Michael F Johnson / Russell Kerr (Sales) 
 Optimum Strategic Communications                  +44 (0) 203 950 9144 
 Mary Clark / Supriya Mathur 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit



(END) Dow Jones Newswires

September 11, 2019 02:01 ET (06:01 GMT)

1 Year Ixico Chart

1 Year Ixico Chart

1 Month Ixico Chart

1 Month Ixico Chart
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191116 00:02:27